Meeting Life Sciences Industry Challenges with ERP

The Life Sciences sector is vast and diverse as it not only covers drugs and vaccinations, but also pharmaceutical and medical devices, extensive R&D, sample testing, and clinical trials. The face of the Life Sciences manufacturing industry is constantly changing with the manufacturers looking for innovation, patient safety, and maintaining quality and hygiene standards with […]

Top Six Reasons Why Compliance Management Is Essential In The Pharmaceutical Industry

The Pharmaceutical Industry has experienced a rapid expansion in the last few years. As a result, the need for strong compliance management becomes all the more indispensable. Performing regulatory scrutiny during every process of a pharmaceutical company, from start to finish is a long and exhaustive process. Not only the process is time-consuming, but it […]

BatchMaster ERP Solution Validated for Pharmaceutical Segment

The main focus of any IT company providing software solution to pharma segment is to deliver solutions that align with cGMP compliance requirements, a mandatory obligation of this sector to regulatory agencies. On this front, BatchMaster solution which also serves the pharmaceutical segment, was tested by a well-known third-party neutral organization ‘OnShore Technology Group’ against […]

Contract Manufacturing Simplified!

Are you a Contract Manufacturer? Are business complexities becoming difficult to handle? Yes? Then, this blog is definitely for you! Finally, it’s raining orders for contract manufacturing units! Blame it on the increasing outsourcing of operations that are doubling the order book for contract manufacturers (CMs). However, contrary to earlier practices when a product went […]

The Heartwarming News for Pharma SMEs!

“Pharma SMEs to benefit from proposed technology upgradation fund” Survey 1: As per the survey conducted by the Department of Pharmaceuticals, and Ministry of Chemical & Fertilizers, only 15% of domestic pharmaceutical manufacturers are making quality drugs of global standards. Reason: non-availability of funds. Survey 2: Moreover, CRISIL believes that technology upgradation by pharma SMEs […]